Strategic partnerships Klarity has recently announced distribution partnerships in the UK with Xiel Ltd and collaboration with Leo Cancer Care to expand upright immobilization devices, signaling a channel-focused growth strategy and potential joint marketing opportunities for international expansion.

Market positioning Operating in medical thermoplastics and patient positioning for radiation therapy with a customer service and user experience emphasis, Klarity presents an opportunity to upsell premium positioning devices and bundled solutions to clinics seeking reliable, high-quality immobilization options.

Growth potential With a mid-size employee base and revenue in the range of one to ten million, Klarity sits in a competitive tier where targeted outreach to mid-market radiotherapy centers and regional distributors could unlock channel-driven revenue growth.

Competitive landscape Competitors span mid to large players in radiotherapy accessories; Klarity’s focus on specialized positioning devices and UK distribution partners suggests a foothold to target clinics seeking differentiated, compliant immobilization solutions and regional support.

Tech and compliance Tech stack demonstrates standard web tooling and security practices; emphasize selling points around product reliability, regulatory compliance, and support infrastructure when engaging procurement teams at radiotherapy centers and distributors.